Statistics for Editorial: FDA-Approved Drug Repositioning for P-Glycoprotein Overexpressing Resistant Cancer
Total visits
| views | |
|---|---|
| Editorial: FDA-Approved Drug Repositioning for P-Glycoprotein Overexpressing Resistant Cancer | 0 |
Total visits per month
| views | |
|---|---|
| May 2024 | 0 |
| June 2024 | 0 |
| July 2024 | 0 |
| August 2024 | 0 |
| September 2024 | 0 |
| October 2024 | 0 |
| November 2024 | 0 |
File Visits
| views | |
|---|---|
| sungpil_fda_2021.pdf | 42 |